Advertisement

Risk Reclassification With Coronary Computed Tomography Angiography-Visualized Nonobstructive Coronary Artery Disease According to 2018 American College of Cardiology/American Heart Association Cholesterol Guidelines (from the Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes : An International Multicenter Registry [CONFIRM])

      The 2018 American College of Cardiology (ACC)/American Heart Association (AHA) cholesterol management guideline recommends risk enhancers in the borderline-risk and statin recommended/intermediate-risk groups. We determined the risk reclassification by the presence and severity of coronary computed tomography angiography (CCTA)-visualized coronary artery disease (CAD) according to statin eligibility groups. Of 35,281 individuals who underwent CCTA, 1,303 asymptomatic patients (age 59, 65% male) were identified. Patients were categorized as low risk, borderline risk, statin recommended/intermediate risk or statin recommended/high risk according to the guideline. CCTA-visualized CAD was categorized as no CAD, nonobstructive, or obstructive. Major adverse cardiovascular events (MACE) were defined as a composite outcome of all-cause mortality, nonfatal myocardial infarction, and late coronary revascularization (>90 days). We tested a reclassification wherein no CAD reclassifies downward, and the presence of any CAD reclassifies upward. During a median follow-up of 2.9 years, 93 MACE events (7.1%) were observed. Among the borderline-risk and statin-recommended/intermediate-risk groups eligible for risk enhancers, the presence or absence of any CCTA-visualized CAD led to a net increase of 2.3% of cases and 22.4% of controls correctly classified (net reclassification index [NRI] 0.27, 95% CI 0.13 to 0.41, p = 0.0002). The NRI was not significant among low- or statin-recommended/high-risk patients (all p >0.05). The presence or absence of CCTA-visualized CAD, including both obstructive and nonobstructive CAD, significantly improves reclassification in patients eligible for risk enhancers in 2018 ACC/AHA guidelines. Patients in low- and high-risk groups derive no significant improvement in risk reclassification from CCTA.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stone NJ
        • Robinson J
        • Lichtenstein AH
        • Merz CNB
        • Blum CB
        • Eckel RH
        • Goldberg AC
        • Gordon D
        • Levy D
        • Lloyd-Jones DM
        • McBride P
        • Schwartz JS
        • Shero ST
        • Smith SC
        • Watson K
        • Wilson PWF
        2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013.
        J Am Coll Cardiol. 2014; 63: 2889-2934
        • Pandya A
        • Sy S
        • Cho S
        • Weinstein MC
        • Gaziano TA
        Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease.
        JAMA. 2015; 314: 142-150
        • Pencina MJ
        • Navar-Boggan AM
        • D'Agostino Sr., RB
        • Williams K
        • Neely B
        • Sniderman AD
        • Peterson ED
        Application of new cholesterol guidelines to a population-based sample.
        N Engl J Med. 2014; 370: 1422-1431
        • Grundy SM
        • Stone NJ
        • Bailey AL
        • Beam C
        • Birtcher KK
        • Blumenthal RS
        • Braun LT
        • de Ferranti S
        • Faiella-Tommasino J
        • Forman DE
        • Goldberg R
        • Heidenreich PA
        • Hlatky MA
        • Jones DW
        • Lloyd-Jones D
        • Lopez-Pajares N
        • Ndumele CE
        • Orringer CE
        • Peralta CA
        • Saseen JJ
        • Smith Jr., SC
        • Sperling L
        • Virani SS
        • Yeboah J
        2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        J Am Coll Cardiol. 2019; 73: 3168-32098
        • Shaw LJ
        • Giambrone AE
        • Blaha MJ
        • Knapper JT
        • Berman DS
        • Bellam N
        • Quyyumi A
        • Budoff MJ
        • Callister TQ
        • Min JK
        Long-term prognosis after coronary artery calcification testing in asymptomatic patients: a cohort study.
        Ann Intern Med. 2015; 163: 14-21
        • Cho I
        • Al'Aref SJ
        • Berger A
        • B OH
        • Gransar H
        • Valenti V
        • Lin FY
        • Achenbach S
        • Berman DS
        • Budoff MJ
        • Callister TQ
        • Al-Mallah MH
        • Cademartiri F
        • Chinnaiyan K
        • Chow BJW
        • DeLago A
        • Villines TC
        • Hadamitzky M
        • Hausleiter J
        • Leipsic J
        • Shaw LJ
        • Kaufmann PA
        • Feuchtner G
        • Kim YJ
        • Maffei E
        • Raff G
        • Pontone G
        • Andreini D
        • Marques H
        • Rubinshtein R
        • Chang HJ
        • Min JK
        Prognostic value of coronary computed tomographic angiography findings in asymptomatic individuals: a 6-year follow-up from the prospective multicentre international CONFIRM study.
        Eur Heart J. 2018; 39: 934-941
        • Wolk MJ
        • Bailey SR
        • Doherty JU
        • Douglas PS
        • Hendel RC
        • Kramer CM
        • Min JK
        • Patel MR
        • Rosenbaum L
        • Shaw LJ
        • Stainback RF
        • Allen JM
        ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2014; 63: 380-406
        • Min JK
        • Dunning A
        • Lin FY
        • Achenbach S
        • Al-Mallah MH
        • Berman DS
        • Budoff MJ
        • Cademartiri F
        • Callister TQ
        • Chang H-J
        • Cheng V
        • Chinnaiyan KM
        • Chow B
        • Delago A
        • Hadamitzky M
        • Hausleiter J
        • Karlsberg RP
        • Kaufmann P
        • Maffei E
        • Nasir K
        • Pencina MJ
        • Raff GL
        • Shaw LJ
        • Villines TC
        Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) Registry.
        J Cardiovasc Comput Tomogr. 2011; 5: 84-92
        • Raff GL
        • Abidov A
        • Achenbach S
        • Berman DS
        • Boxt LM
        • Budoff MJ
        • Cheng V
        • DeFrance T
        • Hellinger JC
        • Karlsberg RP
        SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography.
        J Cardiovasc Comput Tomogr. 2009; 3: 122-136
        • Bittencourt MS
        • Hulten E
        • Ghoshhajra B
        • O'Leary D
        • Christman MP
        • Montana P
        • Truong QA
        • Steigner M
        • Murthy VL
        • Rybicki FJ
        • Nasir K
        • Gowdak LH
        • Hainer J
        • Brady TJ
        • Di Carli MF
        • Hoffmann U
        • Abbara S
        • Blankstein R
        Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events.
        Circ Cardiovasc Imaging. 2014; 7: 282-291
        • Lin FY
        • Shaw LJ
        • Dunning AM
        • Labounty TM
        • Choi JH
        • Weinsaft JW
        • Koduru S
        • Gomez MJ
        • Delago AJ
        • Callister TQ
        • Berman DS
        • Min JK
        Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2-center study of 2,583 patients undergoing 64-detector row coronary computed tomographic angiography.
        J Am Coll Cardiol. 2011; 58: 510-519
        • Maddox TM
        • Stanislawski MA
        • Grunwald GK
        • Bradley SM
        • Ho PM
        • Tsai TT
        • Patel MR
        • Sandhu A
        • Valle J
        • Magid DJ
        • Leon B
        • Bhatt DL
        • Fihn SD
        • Rumsfeld JS
        Nonobstructive coronary artery disease and risk of myocardial infarction.
        JAMA. 2014; 312: 1754-1763
        • Ostrom MP
        • Gopal A
        • Ahmadi N
        • Nasir K
        • Yang E
        • Kakadiaris I
        • Flores F
        • Mao SS
        • Budoff MJ
        Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography.
        J Am Coll Cardiol. 2008; 52: 1335-1343
        • Pencina MJ
        • D'Agostino Sr., RB
        • D'Agostino Jr., RB
        • Vasan RS
        Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.
        Stat Med. 2008; 27 (discussion 207-112): 157-172
        • Pencina MJ
        • D'Agostino Sr., RB
        • Steyerberg EW
        Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.
        Stat Med. 2011; 30: 11-21
        • Emami H
        • Takx RAP
        • Mayrhofer T
        • Janjua S
        • Park J
        • Pursnani A
        • Tawakol A
        • Lu MT
        • Ferencik M
        • Hoffmann U
        Nonobstructive coronary artery disease by coronary CT angiography improves risk stratification and allocation of statin therapy.
        JACC Cardiovasc Imaging. 2017; 10: 1031-1038
        • McClelland RL
        • Jorgensen NW
        • Budoff M
        • Blaha MJ
        • Post WS
        • Kronmal RA
        • Bild DE
        • Shea S
        • Liu K
        • Watson KE
        • Folsom AR
        • Khera A
        • Ayers C
        • Mahabadi AA
        • Lehmann N
        • Jockel KH
        • Moebus S
        • Carr JJ
        • Erbel R
        • Burke GL
        10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) with validation in the HNR (Heinz Nixdorf Recall) study and the DHS (Dallas Heart Study).
        J Am Coll Cardiol. 2015; 66: 1643-1653
        • Greenland P
        • LaBree L
        • Azen SP
        • Doherty TM
        • Detrano RC
        Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals.
        JAMA. 2004; 291: 210-215
        • Andre F
        • Fortner P
        • Vembar M
        • Mueller D
        • Stiller W
        • Buss SJ
        • Kauczor HU
        • Katus HA
        • Korosoglou G
        Improved image quality with simultaneously reduced radiation exposure: Knowledge-based iterative model reconstruction algorithms for coronary CT angiography in a clinical setting.
        J Cardiovasc Comput Tomogr. 2017; 11: 213-220
        • Stehli J
        • Fuchs TA
        • Bull S
        • Clerc OF
        • Possner M
        • Buechel RR
        • Gaemperli O
        • Kaufmann PA
        Accuracy of coronary CT angiography using a submillisievert fraction of radiation exposure: comparison with invasive coronary angiography.
        J Am Coll Cardiol. 2014; 64: 772-780
        • Chow BJ
        • Small G
        • Yam Y
        • Chen L
        • McPherson R
        • Achenbach S
        • Al-Mallah M
        • Berman DS
        • Budoff MJ
        • Cademartiri F
        • Callister TQ
        • Chang HJ
        • Cheng VY
        • Chinnaiyan K
        • Cury R
        • Delago A
        • Dunning A
        • Feuchtner G
        • Hadamitzky M
        • Hausleiter J
        • Karlsberg RP
        • Kaufmann PA
        • Kim YJ
        • Leipsic J
        • LaBounty T
        • Lin F
        • Maffei E
        • Raff GL
        • Shaw LJ
        • Villines TC
        • Min JK
        Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter registry) registry.
        Arterioscler Thromb Vasc Biol. 2015; 35: 981-989
        • Cho YK
        • Nam CW
        • Koo BK
        • Schulman-Marcus J
        • Hartaigh BO
        • Gransar H
        • Lu Y
        • Achenbach S
        • Al-Mallah M
        • Andreini D
        • Bax JJ
        • Budoff MJ
        • Cademartiri F
        • Callister TQ
        • Chang HJ
        • Chinnaiyan K
        • Chow BJW
        • Cury RC
        • Delago A
        • Feuchtner G
        • Hadamitzky M
        • Hausleiter J
        • Kaufmann PA
        • Kim YJ
        • Leipsic J
        • Maffei E
        • Marques H
        • Pontone G
        • Raff GL
        • Rubinshtein R
        • Shaw LJ
        • Villines TC
        • Berman DS
        • Jones EC
        • Pena JM
        • Lin FY
        • Min JK
        Usefulness of baseline statin therapy in non-obstructive coronary artery disease by coronary computed tomographic angiography: From the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) study.
        PLoS One. 2018; 13e0207194
        • Newby DE
        • Adamson PD
        • Berry C
        • Boon NA
        • Dweck MR
        • Flather M
        • Forbes J
        • Hunter A
        • Lewis S
        • MacLean S
        • Mills NL
        • Norrie J
        • Roditi G
        • Shah ASV
        • Timmis AD
        • van Beek EJR
        • Williams MC
        Coronary CT angiography and 5-year risk of myocardial infarction.
        N Engl J Med. 2018; 379: 924-933
        • Bowman L
        • Mafham M
        • Wallendszus K
        • Stevens W
        • Buck G
        • Barton J
        • Murphy K
        • Aung T
        • Haynes R
        • Cox J
        • Murawska A
        • Young A
        • Lay M
        • Chen F
        • Sammons E
        • Waters E
        • Adler A
        • Bodansky J
        • Farmer A
        • McPherson R
        • Neil A
        • Simpson D
        • Peto R
        • Baigent C
        • Collins R
        • Parish S
        • Armitage J
        Effects of aspirin for primary prevention in persons with diabetes mellitus.
        N Engl J Med. 2018; 379: 1529-1539
        • Gaziano JM
        • Brotons C
        • Coppolecchia R
        • Cricelli C
        • Darius H
        • Gorelick PB
        • Howard G
        • Pearson TA
        • Rothwell PM
        • Ruilope LM
        • Tendera M
        • Tognoni G
        Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
        Lancet (London, England). 2018; 392: 1036-1046
        • Min JK
        • Labounty TM
        • Gomez MJ
        • Achenbach S
        • Al-Mallah M
        • Budoff MJ
        • Cademartiri F
        • Callister TQ
        • Chang HJ
        • Cheng V
        • Chinnaiyan KM
        • Chow B
        • Cury R
        • Delago A
        • Dunning A
        • Feuchtner G
        • Hadamitzky M
        • Hausleiter J
        • Kaufmann P
        • Kim YJ
        • Leipsic J
        • Lin FY
        • Maffei E
        • Raff G
        • Shaw LJ
        • Villines TC
        • Berman DS
        Incremental prognostic value of coronary computed tomographic angiography over coronary artery calcium score for risk prediction of major adverse cardiac events in asymptomatic diabetic individuals.
        Atherosclerosis. 2014; 232: 298-304
        • Han D
        • Hartaigh BO
        • Gransar H
        • Lee JH
        • Rizvi A
        • Baskaran L
        • Schulman-Marcus J
        • Dunning A
        • Achenbach S
        • Al-Mallah MH
        • Berman DS
        • Budoff MJ
        • Cademartiri F
        • Maffei E
        • Callister TQ
        • Chinnaiyan K
        • Chow BJW
        • DeLago A
        • Hadamitzky M
        • Hausleiter J
        • Kaufmann PA
        • Raff G
        • Shaw LJ
        • Villines TC
        • Kim YJ
        • Leipsic J
        • Feuchtner G
        • Cury RC
        • Pontone G
        • Andreini D
        • Marques H
        • Rubinshtein R
        • Hindoyan N
        • Jones EC
        • Gomez M
        • Lin FY
        • Chang HJ
        • Min JK
        Incremental prognostic value of coronary computed tomography angiography over coronary calcium scoring for major adverse cardiac events in elderly asymptomatic individuals.
        Eur Heart J Cardiovasc Imaging. 2018; 19: 675-683
        • Wolk MJ
        • Bailey SR
        • Doherty JU
        • Douglas PS
        • Hendel RC
        • Kramer CM
        • Min JK
        • Patel MR
        • Rosenbaum L
        • Shaw LJ
        • Stainback RF
        • Allen JM
        • Brindis RG
        • Kramer CM
        • Shaw LJ
        • Cerqueira MD
        • Chen J
        • Dean LS
        • Fazel R
        • Hundley WG
        • Itchhaporia D
        • Kligfield P
        • Lockwood R
        • Marine JE
        • McCully RB
        • Messer JV
        • O'Gara PT
        • Shemin RJ
        • Wann LS
        • Wong JB
        • Patel MR
        • Kramer CM
        • Bailey SR
        • Brown AS
        • Doherty JU
        • Douglas PS
        • Hendel RC
        • Lindsay BD
        • Min JK
        • Shaw LJ
        • Stainback RF
        • Wann LS
        • Wolk MJ
        • Allen JM
        ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.
        J Card Fail. 2014; 20: 65-90